Skip to main content
. 2015 Sep 14;107(11):djv248. doi: 10.1093/jnci/djv248

Table 2.

Patient toxicity in the National Surgical Adjuvant Breast and Bowel Project R-04 study*

Toxicity Pre-amendment Post-amendment
5-FU, %
(n=141)
CAPE, %
(n=146)
5-FU, %
(n=317)
5-FU
+ OX, %
(n=322)
CAPE, %
(n=319)
CAPE
+ OX, %
(n=322)
Greatest toxicity: Grade 3 28.4 35.6 25.6 37.0 26.6 36.6
Greatest toxicity: Grade 4 2.8 2.7 0.6 2.8 2.2 3.7
Greatest toxicity: Grade 5 0.7 0.7 0.3 0.3 1.3 1.6
Greatest toxicity: Grades 3–5 31.9 39.0 26.5 40.1 30.1 41.9
Toxicity, % of grades observed
Diarrhea: Grades 3-5 15.6 17.1 6.9 16.5 6.9 16.5
Nausea : Grade 3 1.4 2.7 0.3 0.6 1.3 2.2
Vomiting: Grade 3 0 3.4 0.3 1.6 0 1.2
Fatigue: Grade 3 3.5 6.8 1.3 4.0 2.2 5.9
Abdominal pain: Grade 3 2.1 3.4 1.6 2.8 0.3 1.9
Anal pain: Grade 3 1.4 5.5 3.2 4.0 3.4 3.1
Radiation dermatitis: Grades 3–5 2.1 7.5 2.5 2.2 2.5 1.2
Dehydration: Grade 3 5.0 8.2 0.3 2.8 2.2 4.0
Hand-foot syndrome: Grade 3 1.4 3.4 0.3 0 0.3 0.3
Periph. sens. neurop.:Grades 2–4 2.1 2.1 0.6 5.6 2.2 6.5

*5-FU = 5-flourouracil; CAPE = capecitabine; OX = oxaliplatin.